ModelEdge

Bionomics Limited/FI

Filing Type	8-K
Filing Date	7/23/2026
Updated	7/24/26, 7:55 AM

Filing

Earnings Release

Exhibits

8-KMaterial Contracts, Change in Company Ownership, Reg. FD

EX-2.1AGREEMENT AND PLAN OF MERGER, DATED AS OF JULY 23, 2026, BY AND AMONG SCANCELL HOLDINGS PLC, SCANCELL MERGER SUB, INC. AND NEUPHORIA THERAPEUTICS INC

EX-10.1FORM OF COMPANY VOTING AND SUPPORT AGREEMENT

EX-10.2FORM OF PARENT VOTING AND SUPPORT DEED

EX-10.3FORM OF LOCK-UP AGREEMENT

EX-10.4FORM OF CONTINGENT VALUE RIGHTS AGREEMENT

EX-10.5FORM OF SUBSCRIPTION AGREEMENT, BY AND AMONG SCANCELL HOLDINGS PLC, SCANCELL MERGER SUB, INC., NEUPHORIA THERAPEUTICS INC. AND INSTITUTIONAL INVESTORS

EX-10.6FORM OF SUBSCRIPTION AGREEMENT, BY AND AMONG SCANCELL HOLDINGS PLC, SCANCELL MERGER SUB, INC., NEUPHORIA THERAPEUTICS INC. AND INDIVIDUAL INVESTORS

EX-10.7LETTER AGREEMENT, DATED AS OF JULY 20, 2026, BETWEEN NEUPHORIA THERAPEUTICS INC. AND ARMISTICE CAPITAL MASTER FUND LTD

EX-99.1Material Contracts, Change in Company Ownership, Reg. FD

EX-99.2Material Contracts, Change in Company Ownership, Reg. FD